Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM ; volume:16 ; number:1 ; day:31 ; month:1 ; year:2015 ; pages:1-9 ; date:12.2015
BMC immunology ; 16, Heft 1 (31.1.2015), 1-9, 12.2015
- Urheber
-
Deng, Zhenling
Wu, Yanhong
Ma, Wenbo
Zhang, Shuren
Zhang, Yu-Qian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12865-014-0064-x
- URN
-
urn:nbn:de:101:1-2021082120000230648495
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Deng, Zhenling
- Wu, Yanhong
- Ma, Wenbo
- Zhang, Shuren
- Zhang, Yu-Qian
- SpringerLink (Online service)
Ähnliche Objekte (12)
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Adoptive T-cell therapy for Leukemia
T-cell clonotypes in cancer
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Effects of EpCAM overexpression on human breast cancer cell lines
Ligand-based adoptive T cell targeting CA125 in ovarian cancer
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Adoptive T-cell therapy for Leukemia
T-cell clonotypes in cancer
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Effects of EpCAM overexpression on human breast cancer cell lines
Ligand-based adoptive T cell targeting CA125 in ovarian cancer
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Adoptive T-cell therapy for Leukemia
T-cell clonotypes in cancer
EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Effects of EpCAM overexpression on human breast cancer cell lines
Ligand-based adoptive T cell targeting CA125 in ovarian cancer
ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy